Effect of Oxygen Therapy on Incontinence-Associated Dermatitis (IAD)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051357

Enrollment

Unknown

Registered

2021-09-21

Start date

2021-09-21

Completion date

Unknown

Last updated

2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incontinence-Associated Dermatitis (IAD)

Interventions

Treatment group:Routine nursing+oxygen therapy

Control group:Routine nursing

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Consistent with the diagnostic criteria for Incontinence-Associated Dermatitis; 2.Patients with age>= 18 years old, and stay in ICU> 24h; 3.Patients and their families informed consent and volunteered to participate in this study.

Exclusion criteria

Exclusion criteria: 1.Patients with restlessness; 2.Patients with primary skin lesions and damaged skin in local damaged skin; 3.Patients with oxygen allergy; 4.Patients with fracture of both lower limbs and pelvis.

Design outcomes

Primary

Measure	Time frame
Severity scale of Incontinence-Associated Dermatitis;Skin Condition Assessment Sacle;	—

Countries

China

Contacts

Public ContactJiang Tianxiang

Taizhou Hospital of Zhejiang Province

jia313317@126.com+86 18858674053

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026